NCT07269522

Brief Summary

No local data exists regarding the outcomes of anterior cruciate ligament reconstruction by hamstring graft with and without platelet-rich plasma. This study aimed to compare the functional outcomes of arthroscopic anterior cruciate ligament reconstruction by hamstring graft with and without platelet-rich plasma.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 8, 2025

Completed
Last Updated

December 8, 2025

Status Verified

November 1, 2025

Enrollment Period

1.5 years

First QC Date

November 25, 2025

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Anterior Drawer's test

    Number of patients having grade-1 on the Anterior Drawer's test

    12 weeks

  • Lachman's test

    Number of patients having grade-1 on the Lysholm knee score

    12 weeks

  • Lysholm knee score

    A higher Lysholm knee score was labeled as effectiveness of the treatment.

    12 weeks

Study Arms (2)

ACL reconstruction by hamstring graft with PRP group

EXPERIMENTAL

Patients underwent anterior cruciate ligament reconstruction by hamstring graft along with platelet-rich plasma augmentation applying the standard arthroscopic ACL reconstruction technique.

Procedure: ACL reconstruction by hamstring graft with PRP

ACL reconstruction by hamstring graft group

EXPERIMENTAL

Patients underwent anterior cruciate ligament reconstruction by hamstring graft without platelet-rich plasma augmentation applying the standard arthroscopic ACL reconstruction technique.

Procedure: ACL reconstruction by hamstring graft

Interventions

Patients underwent anterior cruciate ligament reconstruction by hamstring graft along with platelet-rich plasma augmentation applying the standard arthroscopic ACL reconstruction technique.

ACL reconstruction by hamstring graft with PRP group

Patients underwent anterior cruciate ligament reconstruction by hamstring graft without platelet-rich plasma augmentation applying the standard arthroscopic ACL reconstruction technique.

ACL reconstruction by hamstring graft group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Any gender
  • Aged 18-40 years
  • With clinically and radiologically confirmed arthroscopic evidence of ACL injury

You may not qualify if:

  • With comprised bilateral ACL tears
  • Lack of fitness due to associated comorbidity
  • Fractures of lower limb bones and/or spine/neurovascular injuries
  • Injuries to other knee ligaments
  • Significant knee joint arthritis
  • Local skin infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lahore General Hospital

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

Anterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and Injuries

Study Officials

  • Naveed Ali, FCPS

    Lahore General Hospital, Lahore, Pakistan

    PRINCIPAL INVESTIGATOR
  • Muhammad Hanif, FCPS

    Lahore General Hospital, Lahore, Pakistan

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Consultant

Study Record Dates

First Submitted

November 25, 2025

First Posted

December 8, 2025

Study Start

January 15, 2022

Primary Completion

June 30, 2023

Study Completion

June 30, 2023

Last Updated

December 8, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Data can be shared on a reasonable request.

Locations